Biopharmaceutical Excipients Global Market Report 2025
상품코드:1889318
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이오의약품 부형제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2024년 29억 9,000만 달러로 평가되었고, 2025년에는 32억 7,000만 달러에 달할 것으로 추정되며, CAGR 9.4%로 확대될 전망입니다. 지난 수년간의 성장은 바이오 의약품에 대한 수요 증가, 만성 질환의 유병률 상승, 통제된 약물 전달에 대한 관심 증가, 바이오의약품 제조 능력 확대, 바이오의약품에 대한 규제 당국의 승인 증가와 관련이 있습니다.
바이오의약품 부형제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 46억 3,000만 달러에 달할 것으로 예측되며, CAGR 9.1%로 성장할 전망입니다. 예측 기간의 성장은 바이오의약품 연구에 대한 투자 확대, 맞춤형 의료의 도입 증가, 위탁제조기관(CMO)에 대한 아웃소싱 증가, 세계적인 콜드체인 인프라의 확충, 첨단 제제 개발에 대한 주력 강화에 의해 견인될 것으로 전망됩니다. 예측 기간 주요 추세는 부형제 적합성 시험의 진보, 약물 전달 기술의 혁신, 지속 가능한 부형제 제조 기술의 개발, 신규 안정제의 연구 개발, 분석적 특성화 기법의 진보를 포함합니다.
백신 개발에 대한 수요 증가는 바이오의약품 부형제 시장의 성장을 이끌 것으로 예측됩니다. 백신 개발은 감염의 예방과 공중 보건의 향상을 목적으로 하는 면역제의 창조 및 제제화를 말합니다. 고품질 부형제는 백신의 안정성, 효능 및 안전성을 보장하는 데 필수적입니다. 백신 수요 증가는 전염병 예방, 공중 보건 시스템 강화, 보다 빠르고 효과적인 예방 접종 솔루션의 조사 가속화를 위한 세계적인 노력을 통해 추진되고 있습니다. 바이오의약품 부형제는 항원의 안정화, 용해성의 향상, 보관 및 유통 시의 완전성 유지를 통해 백신 제제에 있어서 중요한 역할을 합니다. 예를 들어 2025년 미국 질병예방관리센터(CDC)가 발표한 데이터에 따르면 파상풍, 디프테리아 및 무세포 백일해 등 주요 백신에서 사춘기층의 접종률은 2022년 89.9%에서 2024년 91.3%로 상승했습니다. 수막염균 결합 백신의 접종률은 88.6%에서 90.1%로 상승했고, 인유두종 바이러스 백신의 접종률은 동기 사이에 76.0%에서 92.6%로 크게 증가했습니다. 이 예방 접종률의 급증은 백신 개발 수요를 견인해, 결과적으로 바이오의약품 부형제 시장의 성장을 가속하고 있습니다.
바이오의약품 부형제 시장의 기업은 주사제 제형에서 단백질 안정성 향상, 분해 방지, 규제 준수 지원을 목적으로 한 초고순도 계면활성제 등의 기술 혁신에 주력하고 있습니다. 이러한 계면활성제는 불순물을 최소화하고 조성을 균일화한 특수 정제 표면활성제로 민감한 바이오의약품 제제에서 안정성, 안전성, 성능을 보장합니다. 예를 들어, 2025년 9월에 독일의 화학기업 에보닉 인더스트리즈 AG가 주사제 및 바이오의약품 용도를 위한 'MaxiPure Polysorbate 80'을 발표했습니다. 이 부형제는 98% 이상의 올레산 함량, 탁월한 투명성, 유럽 약전, 미국 약국, 일본 약국, 중국 약전의 기준에 대한 완전 준거를 실현하고 있습니다. 본 제품은 단백질 안정성의 과제 해결, 산화 열화 방지, 소수성 유효 성분의 안정적인 가용화를 실현하여 제제의 신뢰성을 높입니다. 에보닉은 본 부형제의 채용에 의해 제약 기업이 복잡한 생물학적 제제나 주사제를 보다 효율적으로 개발함과 동시에 안전성 및 규제 준수를 확보하는 것을 지원하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 바이오의약품 부형제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 바이오의약품 부형제 시장 : 성장률 분석
세계의 바이오의약품 부형제 시장 실적 : 규모 및 성장(2019-2024년)
세계의 바이오의약품 부형제 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 바이오의약품 부형제 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 바이오의약품 부형제 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
바인더
코팅제
희석제
붕괴제
윤활제 및 활제
폴리올
방부제
용해제 및 계면활성제 또는 유화제
현탁제 및 점도제
세계의 바이오의약품 부형제 시장 : 바이오의약품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
항체
백신
세포 요법
기타 생물학적 제제
세계의 바이오의약품 부형제 시장 : 기능성별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
충전제 및 희석제
바인더
현탁제 및 점도제
향료 및 감미료
코팅제
착색제
붕괴제
윤활제 및 활제
방부제
세계의 바이오의약품 부형제 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
주사제 제형
경구 제형
외용 제제
경피 흡수 제제
세포 및 유전자 치료
세계의 바이오의약품 부형제 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
바이오의약품 기업 및 제약 기업
수탁 제조업자
연구기관
세계의 바이오의약품 부형제 시장 : 결합제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
전분계 결합제
셀룰로오스계 결합제
합성 결합제
천연 폴리머 바인더
세계의 바이오의약품 부형제 시장 : 코팅제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
필름 코팅제
당의제
장용성 코팅제
폴리머 코팅
세계의 바이오의약품 부형제 시장 : 희석제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
유당
미결정 셀룰로오스
전분
만니톨
세계의 바이오의약품 부형제 시장 : 붕괴제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
가교 셀룰로오스
전분 유도체
크로스포비돈
나트륨 전분 글리콜레이트
세계의 바이오의약품 부형제 시장 : 윤활제 및 활제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
스테아르산마그네슘
스테아린산
탈크
이산화규소
세계의 바이오의약품 부형제 시장 : 폴리올 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
소르비톨
만니톨
글리세롤
자일리톨
세계의 바이오의약품 부형제 시장 : 보존제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
파라벤
벤조산염
솔베이트
페놀류
세계의 바이오의약품 부형제 시장 : 용해제 및 계면활성제 또는 유화제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
폴리소르베이트
폴리에틸렌글리콜
레시틴
라우릴황산나트륨
세계의 바이오의약품 부형제 시장 : 현탁제 및 점도제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
셀룰로오스 유도체
크산탄검
구아검
카르보머
제7장 지역별 및 국가별 분석
세계의 바이오의약품 부형제 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 바이오의약품 부형제 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
바이오의약품 부형제 시장 : 경쟁 구도
바이오의약품 부형제 시장 : 기업 프로파일
The Archer-Daniels-Midland Company : 개요, 제품 및 서비스, 전략 및 재무 분석
BASF SE : 개요, 제품 및 서비스, 전략 및 재무 분석
The Dow Chemical Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Mitsubishi Chemical Group Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Novo Nordisk A/S : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Associated British Foods plc
Merck KGaA
Asahi Kasei Corporation
Evonik Industries AG
Kerry Group plc
Wacker Chemie AG
Clariant AG
Shin-Etsu Chemical Co. Ltd.
Roquette Freres
IMCD Group NV
Croda International Plc
Ashland Global Holdings Inc.
NOF Corporation
Colorcon Limited
J. Rettenmaier & Sohne GmbH Co. KG
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
바이오의약품 부형제 시장(2029년) : 새로운 기회를 제공하는 국가
바이오의약품 부형제 시장(2029년) : 새로운 기회를 제공하는 부문
바이오의약품 부형제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Biopharmaceutical excipients are inactive components combined with active pharmaceutical ingredients to support the development, stability, and delivery of biologic drugs. They improve the effectiveness, safety, and shelf-life of biopharmaceutical products without providing any therapeutic action themselves. These excipients consist of various substances such as sugars, polymers, and proteins that assist in drug formulation and administration.
The key product types of biopharmaceutical excipients include binders, coatings, diluents, disintegrants, lubricants and glidants, polyols, preservatives, solubilizers and surfactants or emulsifiers, and suspending and viscosity agents. Binders are materials added to powders or granules in pharmaceutical, food, or material formulations to keep ingredients together, ensuring cohesion and structural integrity in the final product. The different types of biologics include antibodies, vaccines, cell therapies, and others. Their multiple functionalities consist of fillers and diluents, binders, suspending and viscosity agents, flavoring agents and sweeteners, coating agents, colorants, disintegrants, lubricants and glidants, and preservatives. The various applications include injectable formulations, oral formulations, topical formulations, transdermal formulations, and cell and gene therapies, and they are used by several end users such as biopharmaceutical and pharmaceutical companies, contract manufacturers, and research institutes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The biopharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical excipients market statistics, including the biopharmaceutical excipients industry global market size, regional shares, competitors with the biopharmaceutical excipients market share, detailed biopharmaceutical excipients market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical excipients industry. This biopharmaceutical excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The biopharmaceutical excipients market size has grown strongly in recent years. It will grow from $2.99 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be linked to increasing demand for biologics, growing prevalence of chronic diseases, rising focus on controlled drug delivery, expansion of biopharmaceutical manufacturing capacity, and increasing regulatory approvals for biologics.
The biopharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $4.63 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be driven by growing investment in biopharmaceutical research, rising adoption of personalized medicine, increasing outsourcing to contract manufacturing organizations, expansion of global cold chain infrastructure, and growing focus on advanced formulation development. Major trends in the forecast period include advancements in excipient compatibility testing, innovations in drug delivery technologies, developments in sustainable excipient manufacturing, research and development in novel stabilizers, and advancements in analytical characterization methods.
The increasing demand for vaccine development is expected to drive the growth of the biopharmaceutical excipients market. Vaccine development involves creating and formulating immunizations to prevent infectious diseases and improve public health. High-quality excipients are essential in ensuring the stability, efficacy, and safety of vaccines. The rising demand for vaccines is driven by global efforts to prevent infectious diseases, strengthen public health systems, and accelerate research for faster, more effective immunization solutions. Biopharmaceutical excipients play a critical role in vaccine formulations by stabilizing antigens, enhancing solubility, and maintaining integrity during storage and distribution. For example, in 2025, the Centers for Disease Control and Prevention (CDC) reported that adolescent vaccination coverage for key vaccines, such as tetanus, diphtheria, and acellular pertussis, increased from 89.9% in 2022 to 91.3% in 2024. Coverage for the meningococcal conjugate vaccine rose from 88.6% to 90.1%, and human papillomavirus vaccine coverage grew significantly from 76.0% to 92.6% over the same period. This surge in immunization coverage is driving the demand for vaccine development and, consequently, the growth of the biopharmaceutical excipients market.
Companies in the biopharmaceutical excipients market are focusing on technological innovations, such as ultra-high purity surfactants, to improve protein stability, prevent degradation, and support regulatory compliance in injectable formulations. These surfactants are specially refined surface-active agents with minimal impurities and consistent composition, ensuring stability, safety, and performance in sensitive biopharmaceutical formulations. For example, in September 2025, Evonik Industries AG, a Germany-based chemicals company, launched MaxiPure Polysorbate 80 for injectable and biopharmaceutical applications. This excipient is engineered with over 98% oleic acid content, exceptional clarity, and full compliance with the European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses challenges in protein stability, prevents oxidative degradation, enables consistent solubilization of hydrophobic active ingredients, and enhances formulation reliability. By integrating this excipient, Evonik helps pharmaceutical companies develop complex biologics and injectable therapies more efficiently while ensuring safety and regulatory compliance.
In May 2025, Roquette Freres, a France-based provider of pharmaceutical excipients, acquired International Flavors & Fragrances (IFF) Pharma Solutions for an undisclosed amount. This acquisition strengthens Roquette's portfolio of pharmaceutical excipients by integrating IFF Pharma Solutions' expertise and innovative products. The move enhances Roquette's ability to deliver high-value drug delivery solutions and support the development of advanced pharmaceutical formulations worldwide. IFF Pharma Solutions, a U.S.-based company, specializes in pharmaceutical excipients and functional ingredients that aid in drug formulation and delivery within the biopharmaceutical industry.
Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Freres, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Sohne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.
North America was the largest region in the biopharmaceutical excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biopharmaceutical excipients report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biopharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biopharmaceutical excipients market consists of sales of growth media, buffer solutions, stabilizers, cryoprotectants, preservatives, surfactants, salts, amino acids, sugars. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biopharmaceutical Excipients Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biopharmaceutical excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biopharmaceutical excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical excipients market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Types: Binders; Coatings; Diluents; Disintegrants; Lubricants And Glidants; Polyols; Preservatives; Solubilizers And Surfactants Or Emulsifiers; Suspending And Viscosity Agents
2) By Type Of Biologics: Antibodies; Vaccines; Cell Therapies; Other Biologics
3) By Functionality: Fillers And Diluents; Binders; Suspending And Viscosity Agents; Flavouring Agents And Sweeteners; Coating Agents; Colourants; Disintegrants; Lubricants And Glidants; Preservatives
4) By Application: Injectable Formulations; Oral Formulations; Topical Formulations; Transdermal Formulations; Cell and Gene Therapy
5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies; Contract Manufacturers; Research Institutes
3. Biopharmaceutical Excipients Market Trends And Strategies
4. Biopharmaceutical Excipients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Biopharmaceutical Excipients Growth Analysis And Strategic Analysis Framework
5.1. Global Biopharmaceutical Excipients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Biopharmaceutical Excipients Market Growth Rate Analysis
5.4. Global Biopharmaceutical Excipients Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Biopharmaceutical Excipients Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Biopharmaceutical Excipients Total Addressable Market (TAM)
6.1. Global Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Binders
Coatings
Diluents
Disintegrants
Lubricants And Glidants
Polyols
Preservatives
Solubilizers And Surfactants Or Emulsifiers
Suspending And Viscosity Agents
6.2. Global Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibodies
Vaccines
Cell Therapies
Other Biologics
6.3. Global Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fillers And Diluents
Binders
Suspending And Viscosity Agents
Flavouring Agents And Sweeteners
Coating Agents
Colourants
Disintegrants
Lubricants And Glidants
Preservatives
6.4. Global Biopharmaceutical Excipients Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Formulations
Oral Formulations
Topical Formulations
Transdermal Formulations
Cell and Gene Therapy
6.5. Global Biopharmaceutical Excipients Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biopharmaceutical Companies And Pharmaceutical Companies
Contract Manufacturers
Research Institutes
6.6. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Binders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Starch Binders
Cellulose Binders
Synthetic Binders
Natural Polymer Binders
6.7. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Coatings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Film Coatings
Sugar Coatings
Enteric Coatings
Polymer Coatings
6.8. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Diluents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lactose
Microcrystalline Cellulose
Starch
Mannitol
6.9. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Disintegrants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Crosslinked Cellulose
Starch Derivatives
Crospovidone
Sodium Starch Glycolate
6.10. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Lubricants And Glidants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Magnesium Stearate
Stearic Acid
Talc
Silicon Dioxide
6.11. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Polyols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sorbitol
Mannitol
Glycerol
Xylitol
6.12. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Preservatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parabens
Benzoates
Sorbates
Phenols
6.13. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Solubilizers And Surfactants Or Emulsifiers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polysorbates
Polyethylene Glycol
Lecithin
Sodium Lauryl Sulfate
6.14. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Suspending And Viscosity Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cellulose Derivatives
Xanthan Gum
Guar Gum
Carbomers
7. Biopharmaceutical Excipients Market Regional And Country Analysis
7.1. Global Biopharmaceutical Excipients Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Biopharmaceutical Excipients Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biopharmaceutical Excipients Market
9.1. China Biopharmaceutical Excipients Market Overview
9.2. China Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biopharmaceutical Excipients Market
10.1. India Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biopharmaceutical Excipients Market
11.1. Japan Biopharmaceutical Excipients Market Overview
11.2. Japan Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biopharmaceutical Excipients Market
12.1. Australia Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biopharmaceutical Excipients Market
13.1. Indonesia Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biopharmaceutical Excipients Market
14.1. South Korea Biopharmaceutical Excipients Market Overview
14.2. South Korea Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biopharmaceutical Excipients Market
15.1. Western Europe Biopharmaceutical Excipients Market Overview
15.2. Western Europe Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biopharmaceutical Excipients Market
16.1. UK Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biopharmaceutical Excipients Market
17.1. Germany Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biopharmaceutical Excipients Market
18.1. France Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biopharmaceutical Excipients Market
19.1. Italy Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biopharmaceutical Excipients Market
20.1. Spain Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biopharmaceutical Excipients Market
21.1. Eastern Europe Biopharmaceutical Excipients Market Overview
21.2. Eastern Europe Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biopharmaceutical Excipients Market
22.1. Russia Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biopharmaceutical Excipients Market
23.1. North America Biopharmaceutical Excipients Market Overview
23.2. North America Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biopharmaceutical Excipients Market
24.1. USA Biopharmaceutical Excipients Market Overview
24.2. USA Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biopharmaceutical Excipients Market
26.1. South America Biopharmaceutical Excipients Market Overview
26.2. South America Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biopharmaceutical Excipients Market
27.1. Brazil Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biopharmaceutical Excipients Market
28.1. Middle East Biopharmaceutical Excipients Market Overview
28.2. Middle East Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biopharmaceutical Excipients Market
29.1. Africa Biopharmaceutical Excipients Market Overview
29.2. Africa Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biopharmaceutical Excipients Market Competitive Landscape And Company Profiles
